U.S. Cyclospora cases mount as CDC lags on tracking
On Jul. 9, 2026, the Center for Infectious Disease Research & Policy reported that in parts of the…
On Jul. 9, 2026, the Center for Infectious Disease Research & Policy reported that in parts of the…
On July 9, 2026, researchers at the University of British Columbia announced they have identified a new form of hereditary…
On Jul. 8, 2026, a team of surgeons at the University of California San Diego report that for…
On Jul. 7, 2026, the World Health Organization (WHO) reported that the outbreak of the deadly Bundibugyo species of…
On Jul. 7, 2026, the U.S. Food and Drug Administration has approved Vera Therapeutics’ drug to treat patients…
On Jul. 6, 2026, Novartis announced it has reached an agreement to acquire Myricx Bio for up to…
On Jul. 1, 2026, a study led by a researcher based at King’s College London and McMaster University…
On Jul. 1, 2026, Associate Professors Kate Adamala and Aaron Engelhart and their teams at the College of…
On Jul. 1, 2026, Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, announced a strategic…
On Jul. 1, 2026, Professor Chih-Ying Su, previously Professor and Vice Chair of the Department of Neurobiology at…
On Jul. 1, 2026, tech giant Anthropic announced it has extended its foray into the life sciences space…
On Jun. 30, 2026, The U.S. Department of Health and Human Services (HHS) announced that Secretary Robert F….
On Jun. 29, 2026, AstraZeneca and Daiichi Sankyo’s announced that Enhertu (trastuzumab deruxtecan) had been approved in the…
On Jun. 26, 2026, Chronic diabetic wounds heal slowly and are highly vulnerable to infection. Researchers report developing…
On Jun. 25, 2026, researchers from the Nara Institute of Science and Technology report that every time a…
On Jun. 24, 2026, A University of Southern California (USC)-led study finds Alzheimer’s disease and related dementias will…
On Jun. 24, 2026, Antares Therapeutics announce it has entered a collaboration with Novartis that could be worth…
On Jun. 24, 2026, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy®…
On Jun. 23. 2026, scientists at Cornell University announce discovering a delivery system that uses lipid nanoparticles to…
On Jun. 23, 2026, the U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for…
On Jun. 22, 2026, Louisiana’s first Sickle Cell Disease gene therapy patient is now set to pursue his…
On Jun. 19, 2026, University of Southern California (USC) scientists report in a paper published in Cell, a…
On Jun. 17, 2026, Biogen and RayThera, a private biotechnology company focused on discovering and developing small molecule…
On Jun. 16, 2026, the U.S. Food and Drug Administration (FDA) approved another over-the-counter (OTC) intranasal naloxone product,…
On Jun. 16, 2026, the U.S. Department of Agriculture (USDA) is announcing funding for 40 breakthrough projects to…
On Jun. 11, 2026, the University of Oklahoma (OU) announced it had received an $11.5 million award from…
On Jun. 11, 2026, The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for generic…
On Jun. 9, 2026, The U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS), alongside…
On Jun. 8, 2026, an eight-month-old infant with a severe genetic epilepsy has become the first patient in…
On Jun. 8, 2026, the Wellcome Sanger Institute, Google.org, and Google DeepMind announced they are partnering up to…